Specgx Llc Drug Patent Portfolio
Specgx Llc owns 2 orange book drugs protected by 3 US patents Given below is the list of Specgx Llc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7691880 | Methylphenidate solution and associated methods of administration and production | 07 Oct, 2024 | Expired |
| US5702725 | Hydromorphone therapy | 07 Jul, 2014 | Expired |
| US5914131 | Hydromorphone therapy | 07 Jul, 2014 | Expired |
Latest Legal Activities on Specgx Llc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Specgx Llc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 06 Oct, 2021 | US7691880 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 06 Oct, 2017 | US7691880 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 06 Apr, 2010 | US7691880 |
|
Recordation of Patent Grant Mailed
Critical
| 06 Apr, 2010 | US7691880 |
|
Issue Notification Mailed
Critical
| 17 Mar, 2010 | US7691880 |
| Dispatch to FDC | 01 Mar, 2010 | US7691880 |
|
Application Is Considered Ready for Issue
Critical
| 25 Feb, 2010 | US7691880 |
|
Issue Fee Payment Verified
Critical
| 18 Feb, 2010 | US7691880 |
|
Issue Fee Payment Received
Critical
| 18 Feb, 2010 | US7691880 |
|
Mail Notice of Allowance
Critical
| 26 Jan, 2010 | US7691880 |
| Mail Examiner's Amendment | 26 Jan, 2010 | US7691880 |
|
Notice of Allowance Data Verification Completed
Critical
| 21 Jan, 2010 | US7691880 |
|
Case Docketed to Examiner in GAU
Critical
| 21 Jan, 2010 | US7691880 |
| Interview Summary Record | 14 Jan, 2010 | US7691880 |
| Disposal for a RCE / CPA / R129 | 10 Dec, 2009 | US7691880 |
Specgx Llc's Family Patents
Specgx Llc Drug List
Given below is the complete list of Specgx Llc's drugs and the patents protecting them.
1. Exalgo
Exalgo is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5702725 | Hydromorphone therapy |
07 Jul, 2014
(10 years ago)
| Expired |
| US5914131 | Hydromorphone therapy |
07 Jul, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Exalgo's drug page
2. Methylin
Methylin is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7691880 | Methylphenidate solution and associated methods of administration and production |
07 Oct, 2024
(a month ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Methylin's drug page